ISRCTN98638368已完成不适用
Does allopurinol/urate lowering by xanthine oxidase inhibition have an impact on arterial stiffness in stroke survivors?
niversity of Dundee (UK)0 个研究点目标入组 120 人开始时间: 2006年12月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Stroke survivors who have a high serum urate
排除标准
- •1. Documented reaction to allopurinol
- •2. Persons who were incapable of giving informed consent
研究者
相似试验
进行中（未招募）
1 期
Does allopurinol (a xanthine oxidase inhibitor) have clinically useful anti-ischaemic effects in angina pectoris? - A randomised, double-blind, placebo-controlled trialAngina PectorisEUCTR2006-004611-21-GBniversity of Dundee
招募中
不适用
Association between xanthine oxidoreductase activity and diabetes complications in patients with type 1 diabetestype 1 diabetes mellitusJPRN-UMIN000031328Hyogo College of Medicine100
已完成
不适用
Analysis of contribution of xanthine oxidoreductase on the onset and progression of vascular complications in patients with type 2 diabetes.Type 2 diabetes mellitusJPRN-UMIN000029257ihon University Hospital100
已完成
2 期
Intravenous Allopurinol in Heart FailureCongestive Heart FailureNCT00181155Johns Hopkins University18
已完成
不适用
Do xanthine oxidase inhibitors reduce both left ventricular hypertrophy and endothelial dysfunction in cardiovascular patients with renal dysfunction?Chronic kidney disease (CKD) and left ventricular hypertrophy (LVH)Circulatory SystemComplications and ill-defined descriptions of heart diseaseISRCTN45773760niversity of Dundee (UK)60